SU-MED INTERNATIONAL (UK) LIMITED

Company Registration Number:
01961001 (England and Wales)

Unaudited abridged accounts for the year ended 31 January 2024

Period of accounts

Start date: 01 February 2023

End date: 31 January 2024

SU-MED INTERNATIONAL (UK) LIMITED

Contents of the Financial Statements

for the Period Ended 31 January 2024

Balance sheet
Notes

SU-MED INTERNATIONAL (UK) LIMITED

Balance sheet

As at 31 January 2024


Notes

2024

2023


£

£
Called up share capital not paid: 0 1,080
Fixed assets
Intangible assets: 3 6,563 0
Tangible assets: 4 867,111 840,043
Investments: 5 116,818 116,818
Total fixed assets: 990,492 956,861
Current assets
Stocks: 711,123 657,016
Debtors:   430,398 437,340
Cash at bank and in hand: 30,010 20,629
Investments:   0 0
Total current assets: 1,171,531 1,114,985
Creditors: amounts falling due within one year:   (728,481) (669,859)
Net current assets (liabilities): 443,050 445,126
Total assets less current liabilities: 1,433,542 1,403,067
Creditors: amounts falling due after more than one year:   (544,830) (567,750)
Provision for liabilities: 0 0
Total net assets (liabilities): 888,712 835,317
Capital and reserves
Called up share capital: 818,564 818,564
Share premium account: 377,792 377,792
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: (307,644) (361,039)
Shareholders funds: 888,712 835,317

The notes form part of these financial statements

SU-MED INTERNATIONAL (UK) LIMITED

Balance sheet statements

For the year ending 31 January 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 12 March 2024
and signed on behalf of the board by:

Name: Graham Collyer
Status: Director

The notes form part of these financial statements

SU-MED INTERNATIONAL (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Tangible fixed assets and depreciation policy

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows: Freehold property - Depreciated straight line over 50 years Leasehold improvements - Depreciated over 20 years, or the length of the lease, if less Plant and Machinery - Straight line basis, over the expected life of the asset Fixtures, fittings and equipment - 10% straight line Computer equipment - 20% straight line

Intangible fixed assets and amortisation policy

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset, as follows: Development costs: Amortised over the expected life of the project

SU-MED INTERNATIONAL (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2024

2. Employees

2024 2023
Average number of employees during the period 29 26

SU-MED INTERNATIONAL (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2024

3. Intangible Assets

Total
Cost £
At 01 February 2023 199,646
Additions 7,876
At 31 January 2024 207,522
Amortisation
At 01 February 2023 199,646
Charge for year 1,313
At 31 January 2024 200,959
Net book value
At 31 January 2024 6,563
At 31 January 2023 0

SU-MED INTERNATIONAL (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2024

4. Tangible Assets

Total
Cost £
At 01 February 2023 1,441,142
Additions 49,878
Disposals (896)
At 31 January 2024 1,490,124
Depreciation
At 01 February 2023 601,099
Charge for year 22,153
On disposals (239)
At 31 January 2024 623,013
Net book value
At 31 January 2024 867,111
At 31 January 2023 840,043

SU-MED INTERNATIONAL (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 January 2024

5. Fixed investments

Investment in Tradmalt (Plastics) Ltd and Easy Access Showers Ltd